New Delhi: US cardiology groups have released updated cholesterol guidelines advising against the use of over-the-counter fish oil and similar supplements to reduce LDL cholesterol, citing limited benefit and possible risks. The 2026 revision recommends earlier cholesterol screening, stricter LDL targets and consideration of statin therapy in high-risk individuals even in their 30s. Experts underline lifestyle changes and prescription medicines as more reliable tools to lower heart disease risk.
(Detailed copy to come)